Results 181 to 190 of about 10,662,454 (348)

P1185: ANTITUMOR ACTIVITY AND SAFETY OF ZANUBRUTINIB COMBINED WITH R-CHOP REGIMEN IN THE TREATMENT OF NEWLY DIAGNOSED NON-GCB DLBCL WITH EXTRANODAL INVOLVEMENT: A PROSPECTIVE PHASE II STUDY.

HemaSphere, 2022
C. Li, H. Geng, X. Zong, J. Zhou, Y. Zhang, J. Li, S. Jia, D. Wu   +7 more
doaj   +1 more source

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era. [PDF]

Front Oncol
Okamoto A, Yoshida M, Kasahara S, Ara T, Ozeki K, Morishita T, Ikeda D, Kanaya M, Kajiguchi T, Suzuki Y, Kurahashi S, Horio T, Marumo Y, Oyake T, Saito S, Sawa H, Kimura SI, Nishiyama T, Kondo E, Hiraga J, Hosoi H, Masaki Y, Atsuta Y, Yamamoto H, Miyama T, Goto N, Iriyama C, Mihara K, Inamoto Y, Tomita A.   +29 more
europepmc   +1 more source

A Cryoprotectant‐Compatible Nanoporous Platform for Stable and Scalable Delivery of Biopharmaceuticals

Advanced Materials, EarlyView.
A cryoprotectant‐compatible nanoporous platform enables ambient‐stable and scalable delivery of gene editing therapeutics. By combining hierarchical pore architecture with optimized lyophilization chemistry, the system preserves Cas9‐RNP activity post‐freeze‐drying.
Sian Lee, Seongchan Kim, Jooyeun Chong, Min‐gyeong Kim, Kayeong Lim, Nan‐Ee Lee, Jahyun Koo, Jiheong Kang, Hyojin Lee   +8 more
wiley   +1 more source

Clinical characteristics and prognostic factors of <i>Clostridium perfringens</i> infection complicated by massive intravascular hemolysis in patients with hematologic diseases: a retrospective case series study. [PDF]

Front Med (Lausanne)
Lin W, Feng J, Fang Z.
europepmc   +1 more source

Performance Comparison of Procalcitonin, Delta Neutrophil Index, C-Reactive Protein, and Serum Amyloid A Levels in Patients with Hematologic Diseases. [PDF]

Diagnostics (Basel), 2023
Cho J, Lee JH, Lee DH, Kim J, Uh Y.
europepmc   +1 more source

A Nano‐Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast‐Immune Communication via CCL2 Sequestration

Advanced Materials, EarlyView.
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen, Gao Wei, Guowei Zeng, Haoyu Li, Rongrong Wu, Hongyu Yan, Zijie Zhou, Kai Luo, Xiaoyang Zhang, Cong Li, Longming Huang, Lingyan Cheng, Xinjie Zhang, Jinghao Zheng, Bozhong Shi, Xiaojun Cai, Xiaomin He   +16 more
wiley   +1 more source

P394: FRONTLINE COMBINATION OF OLVEREMBATINIB AND PDT-ALL-2016 PEDIATRIC INSPIRED PROTOCOL IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2023
Kaibo Zhu, Ting Zhang, Zhixiang Wang, Qifa Liu, Hongsheng Zhou   +4 more
doaj   +1 more source

Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases. [PDF]

Front Pharmacol
Xu J, Lin J, Gan H, He Q, Wang W, Liu Y.
europepmc   +1 more source

Efficacy and Safety Assessment of 5‐Fluorouracil, Irinotecan and Oxaliplatin‐Loaded Implants in Mouse and Pig Models for Pancreatic Cancer Therapy

Advanced Materials, EarlyView.
A novel FIRINOX‐loaded implant demonstrates controlled drug release, and potent therapeutic efficacy in pancreatic ductal adenocarcinoma mouse models with safety confirmed in a large‐animal pre‐clinical model. This innovative drug delivery platform offers a promising new treatment approach for non‐resectable, treatment‐resistant pancreatic cancer ...
Samantha J. Wade, Ashna A. Kumar, Samuel O. Nitschke, Paul Joyce, Elahe Minaei, Stephanie E. Reuter, Chelsea Penney, Holly Warren, Ruby Shepherd, Jeremy N. Dinoro, Gordon G. Wallace, Anthony Dosseto, Sameera Ansar, Naila Islam, Alistair Lochhead, George Sharbeen, Phoebe A. Phillips, Morteza Aghmesheh, Wayne J. Hawthorne, Kara L. Vine‐Perrow   +19 more
wiley   +1 more source

Isavuconazole Therapy for Patients with Hematologic Diseases and Hematopoietic Cell Transplantation with and Without Breakthrough Invasive Fungal Infections. [PDF]

J Fungi (Basel)
Herrera F, Torres D, Mendez G, Mañez N, Jordán R, Manzur A, Cabral M, Alderete M, García Allende N, Benso J, Salgueira C, Pereyra ML, Peretti H, Niveyro C, Castro M, Pollastrelli F, García Rojas S, Dapás J, Risso Patrón A, Fernández V, Gago R, Afeltra J, Multicenter study on Isavuconazole for Treatment and Prophylaxis of Invasive Fungal Infections in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation (EMISA).   +22 more
europepmc   +1 more source